Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
The New England Journal of Medicine|June 25, 2020
Effects of Allopurinol on the Progression of Chronic Kidney DiseaseSunil V Badve, Elaine M Pascoe, Anushree Tiku, et al.
Nutrients|November 5, 2020
Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney DiseaseAnnette T Y Wong, Alexandra Munt, Margaret Allman-Farinelli, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Clinical Kidney Journal|January 19, 2026
Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studiesMicky Karsten, Sunil V Badve, Ron T Gansevoort, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2025
Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney DiseaseWisanne M Bakker, Hiddo J L Heerspink, Stefan P Berger, et al.
BMJ Open|January 24, 2018
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)Annette T Y Wong, Carly Mannix, Jared J Grantham, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Journal of the American Society of Nephrology : JASN|September 12, 2020
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)Nigel D Toussaint, Eugenia Pedagogos, Nicole M Lioufas, et al.
Pageof 15